Tower Research Capital (TRC)’s Eucrates Biomedical Acquisition Corp. Unit EUCRU Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2022
Q3
Sell
-100
Closed -$1K 6785
2022
Q2
$1K Buy
+100
New +$1K ﹤0.01% 5955
2021
Q4
Sell
-95
Closed -$1K 6816
2021
Q3
$1K Hold
95
﹤0.01% 5603
2021
Q2
$1K Hold
95
﹤0.01% 5316
2021
Q1
$1K Sell
95
-1
-1% -$11 ﹤0.01% 5254
2020
Q4
$1K Buy
+96
New +$1K ﹤0.01% 5059